STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 96 filers reported holding STOKE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $450 | -17.7% | 42,300 | -35.6% | 0.00% | 0.0% |
| Q1 2023 | $547 | -43.3% | 65,700 | -37.2% | 0.00% | 0.0% |
| Q4 2022 | $965 | -99.9% | 104,600 | -17.5% | 0.00% | -50.0% |
| Q3 2022 | $1,628,000 | -19.9% | 126,800 | -17.6% | 0.00% | 0.0% |
| Q2 2022 | $2,033,000 | +697.3% | 153,900 | +1171.9% | 0.00% | – |
| Q1 2022 | $255,000 | -87.9% | 12,100 | -85.4% | 0.00% | -100.0% |
| Q3 2021 | $2,106,000 | -23.1% | 82,800 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $2,737,000 | +35.0% | 81,300 | +55.7% | 0.00% | 0.0% |
| Q1 2021 | $2,027,000 | – | 52,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |